Loomis, Sayles & Company’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,609,013
| Closed | -$30.8M | – | 708 |
|
|
2024
Q2 | $30.8M | Sell |
1,609,013
-502,102
| -24% | -$9.6M | 0.04% | 183 |
|
|
2024
Q1 | $69.2M | Buy |
2,111,115
+115,503
| +6% | +$3.79M | 0.1% | 89 |
|
|
2023
Q4 | $65.9M | Sell |
1,995,612
-49,001
| -2% | -$1.62M | 0.1% | 92 |
|
|
2023
Q3 | $55.7M | Sell |
2,044,613
-196,807
| -9% | -$5.36M | 0.1% | 102 |
|
|
2023
Q2 | $67.9M | Sell |
2,241,420
-37,407
| -2% | -$1.13M | 0.11% | 89 |
|
|
2023
Q1 | $73.9M | Buy |
2,278,827
+362,544
| +19% | +$11.8M | 0.13% | 82 |
|
|
2022
Q4 | $53.8M | Sell |
1,916,283
-712,701
| -27% | -$20M | 0.11% | 104 |
|
|
2022
Q3 | $94.5M | Buy |
2,628,984
+114,793
| +5% | +$4.12M | 0.19% | 66 |
|
|
2022
Q2 | $77.2M | Sell |
2,514,191
-12,768
| -0.5% | -$392K | 0.14% | 69 |
|
|
2022
Q1 | $81.6M | Buy |
2,526,959
+544,667
| +27% | +$17.6M | 0.11% | 79 |
|
|
2021
Q4 | $54.9M | Buy |
1,982,292
+394,503
| +25% | +$10.9M | 0.07% | 133 |
|
|
2021
Q3 | $49.2M | Buy |
1,587,789
+714,787
| +82% | +$22.2M | 0.06% | 148 |
|
|
2021
Q2 | $18.4M | Buy |
+873,002
| New | +$18.4M | 0.02% | 314 |
|
|
2019
Q1 | – | Sell |
-767,446
| Closed | -$15.3M | – | 803 |
|
|
2018
Q4 | $15.3M | Buy |
+767,446
| New | +$15.3M | 0.04% | 218 |
|
|
2017
Q1 | – | Sell |
-400,607
| Closed | -$5.93M | – | 972 |
|
|
2016
Q4 | $5.93M | Sell |
400,607
-172,205
| -30% | -$2.55M | 0.01% | 506 |
|
|
2016
Q3 | $14.1M | Buy |
+572,812
| New | +$14.1M | 0.04% | 357 |
|
|
2015
Q4 | – | Sell |
-49,241
| Closed | -$786K | – | 1069 |
|
|
2015
Q3 | $786K | Buy |
49,241
+17,192
| +54% | +$274K | ﹤0.01% | 571 |
|
|
2015
Q2 | $625K | Buy |
+32,049
| New | +$625K | ﹤0.01% | 595 |
|